Association between survivin gene promoter -31G/C and -644C/T polymorphisms and non-small cell lung cancer

Genetics and Molecular Research

Volumn 12, Issue 3, 2013, Pages 3975-3982

  Aynaci, E ^a   Coskunpinar, E ^b   Eren, A ^b   Kum, O ^a   Oltulu, Y M ^b   Akkaya, N ^b   Turna, A ^c   Yaylim, I ^b   Yildiz, P ^a  

^a Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Biomarker; Gene polymorphism; Genetics; Non small cell lung cancer; Survivin

Indexed keywords

SURVIVIN;

ADULT; ARTICLE; CANCER PROGNOSIS; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HAPLOTYPE; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PROMOTER REGION; SMOKING; SURVIVIN GENE; TURKEY (REPUBLIC);

CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 17; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; GENOTYPE; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; LOGISTIC MODELS; MULTIVARIATE ANALYSIS; POLYMORPHISM, GENETIC; PROGNOSIS; PROMOTER REGIONS, GENETIC; TURKEY;

EID: 84884835649     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2013.February.28.9     Document Type: Article

References (22)

1. Adida C, Crotty PL, McGrath J, Berrebi D, et al. (1998). Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation. Am. J. Pathol. 152: 43-49.
2. Altieri DC (2003). Validating survivin as a cancer therapeutic target. Nat. Rev. Cancer 3: 46-54.
3. Chiou SK, Jones MK and Tarnawski AS (2003). Survivin-an anti-apoptosis protein: its biological roles and implications for cancer and beyond. Med. Sci. Monit. 9: I25-I29.
4. Dai J, Jin G, Dong J, Chen Y, et al. (2010). Prognostic significance of survivin polymorphisms on non-small cell lung cancer survival. J. Thorac. Oncol. 5: 1748-1754.
5. Deveraux QL, Takahashi R, Salvesen GS and Reed JC (1997). X-linked IAP is a direct inhibitor of cell-death proteases. Nature 388: 300-304.
6. Drábek J and Petrek M (2002). A sugar, laundry detergent, and salt method for extraction of deoxyribonucleic acid from blood. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. 146: 37-39.
7. Gazouli M, Tzanakis N, Rallis G, Theodoropoulos G, et al. (2009). Survivin-31G/C promoter polymorphism and sporadic colorectal cancer. Int. J. Colorectal Dis. 24: 145-150.
8. Jang JS, Kim KM, Kang KH, Choi JE, et al. (2008). Polymorphisms in the survivin gene and the risk of lung cancer. Lung Cancer 60: 31-39.
9. Jiang Y, De Bruin A, Caldas H, Fangusaro J, et al. (2005). Essential role for survivin in early brain development. J. Neurosci. 25: 6962-6970.
10. Kawamura K, Sato N, Fukuda J, Kodama H, et al. (2003). Survivin acts as an antiapoptotic factor during the development of mouse preimplantation embryos. Dev. Biol. 256: 331-341.
11. Lan CC, Wu YK, Lee CH, Huang YC, et al. (2010). Increased survivin mRNA in malignant pleural effusion is significantly correlated with survival. Jpn. J. Clin. Oncol. 40: 234-240.
12. Li F and Altieri DC (1999). The cancer antiapoptosis mouse survivin gene: characterization of locus and transcriptional requirements of basal and cell cycle-dependent expression. Cancer Res. 59: 3143-3151.
13. Li F and Brattain MG (2006). Role of the survivin gene in pathophysiology. Am. J. Pathol. 169: 1-11.
14. Marusawa H, Matsuzawa S, Welsh K, Zou H, et al. (2003). HBXIP functions as a cofactor of survivin in apoptosis suppression. EMBO J. 22: 2729-2740.
15. Miller SA, Dykes DD and Polesky HF (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16: 1215.
16. Murphy CR, Sabel JL, Sandler AD and Dagle JM (2002). Survivin mRNA is down-regulated during early Xenopus laevis embryogenesis. Dev. Dyn. 225: 597-601.
17. Nachmias B, Ashhab Y and Ben-Yehuda D (2004). The inhibitor of apoptosis protein family (IAPs): an emerging therapeutic target in cancer. Semin. Cancer Biol. 14: 231-243.
18. Park SK, Cho LY, Yang JJ, Park B, et al. (2010). Scientific Committee, Korean Academy of Tuberculosis and Respiratory Diseases. Lung cancer risk and cigarette smoking, lung tuberculosis according to histologic type and gender in a population based case-control study. Lung Cancer 68: 20-26.
19. Shinohara ET, Gonzalez A, Massion PP, Chen H, et al. (2005). Nuclear survivin predicts recurrence and poor survival in patients with resected nonsmall cell lung carcinoma. Cancer 103: 1685-1692.
20. Wang X, Huang L, Xu Y, Shi Z, et al. (2012). Association between survivin-31G > C promoter polymorphism and cancer risk: a meta-analysis. Eur. J. Hum. Genet. 20: 790-795.
21. Xu Y, Fang F, Ludewig G, Jones G, et al. (2004). A mutation found in the promoter region of the human survivin gene is correlated to overexpression of survivin in cancer cells. DNA Cell Biol. 23: 419-429.
22. Yang X, Xiong G, Chen X, Xu X, et al. (2009). Polymorphisms of survivin promoter are associated with risk of esophageal squamous cell carcinoma. J. Cancer Res. Clin. Oncol;. 135: 1341-1349.